Drug_Abuse | NACDS

NACDS Comments to SAMHSA Highlight the Critical Role of Pharmacies in Expanding Access to Opioid Use Disorder Treatment Services Call on SAMHSA to help ensure that the regulatory framework for medications for opioid use disorder treatment continues to accommodate evolving practice models that deliver treatment services in new and innovative ways – and in different patient care settings

admin2023-02-16T14:22:46-05:00Categories: Press Release|Tags: DEA, Drug Safety, Drug_Abuse, Pharmacy_Value|

Call on SAMHSA to help ensure that the regulatory framework for medications for opioid use disorder treatment continues to accommodate evolving practice models that deliver treatment services in new and innovative ways – and in different patient care settings.

In Case You Missed It: White House Celebrates End of X-Waiver Requirement, NACDS-Backed Law Change Included in December Omnibus Bill

admin2023-01-26T09:19:50-05:00Categories: In Case You Missed It|Tags: DEA, Drug_Abuse, Drug_Safety|

A White House ceremony on Tuesday marked the end of the “X-waiver” requirement.

NACDS Urges Action to Help Curb Prescription Drug Misuse and Abuse Comments to Centers for Medicare & Medicaid Services call for enforcement of electronic prescribing of controlled substances requirements no later than January 1, 2023

admin2022-09-29T10:48:07-04:00Categories: Press Release|Tags: CMS, Congress, Drug_Abuse|

Comments to Centers for Medicare & Medicaid Services call for enforcement of electronic prescribing of controlled substances requirements no later than January 1, 2023.

NACDS Applauds Passage of Opioid Prescription Verification Act by U.S. House of Representatives Legislation would help reduce drug abuse and misuse by continuing to advance electronic prescribing

admin2021-12-09T15:15:57-05:00Categories: Press Release|Tags: Congress, Drug_Abuse|

Legislation would help reduce drug abuse and misuse by continuing to advance electronic prescribing.

NACDS Regional Chain Conference Underscores Resilience, Commitment, Community-Focus of Retail Pharmacy Throughout COVID Pandemic Virtual event brings together traditional drug and grocery chains with between four and 250 locations, and their supplier partners; features insights and collaboration on diverse health-and-wellness and front-end topics

admin2021-02-10T12:03:48-05:00Categories: Press Release|Tags: Conferences, DIR, Drug_Abuse, Pharmacy_Value, Preparedness, Regional_Chain_Conference, Reimbursement|

Virtual event brings together traditional drug and grocery chains with between four and 250 locations, and their supplier partners; features insights and collaboration on diverse health-and-wellness and front-end topics.

NACDS Backs “Partial Fill” Concept to Curb Opioid Abuse, Makes Recommendations to DEA for Success of New Rule Goal is careful use of prescription opioids and reduction of quantity of unused controlled substances that could be diverted or abused

admin2021-02-03T15:03:35-05:00Categories: Press Release|Tags: DEA, Drug_Abuse|

Goal is careful use of prescription opioids and reduction of quantity of unused controlled substances that could be diverted or abused.

NACDS Among Coalition Members Urging Implementation Without Delay for Electronic Prescribing of Controlled Substances Letter to Congress asks that “CMS promptly undertakes the requisite rulemaking so that the agency is able to establish a January 1, 2022 deadline for EPCS compliance” to help address opioid-abuse issues

admin2020-12-10T12:47:30-05:00Categories: Press Release|Tags: Congress, Drug_Abuse|

A letter to Congress asks that the Centers for Medicare & Medicaid Services "promptly undertakes the requisite rulemaking so that the agency is able to establish a January 1, 2022 deadline for EPCS compliance” to help address opioid-abuse issues.

NACDS Urges Mandatory Electronic Prescriptions for Controlled Substances Comments to DEA call electronic prescribing an “important tool to improve patient health outcomes and combat the misuse, abuse, and diversion of controlled substances”

admin2020-06-26T15:19:44-04:00Categories: Press Release|Tags: DEA, Drug_Abuse|

NACDS is urging the DEA to make electronic prescriptions for controlled substances (EPCS) mandatory.

NACDS Applauds Maryland E-prescribing Law to Help Prevent Opioid Abuse

admin2020-05-14T13:33:16-04:00Categories: Press Release|Tags: Drug_Abuse, States|

The State of Maryland has taken another important step forward to enhance the security of controlled-substances prescriptions and to reduce the likelihood of fraudulent prescribing.

Substance Use Disorder Needs Pharmacists’ Help, NACDS Says NACDS writes to 14 states and D.C. as they explore solutions

admin2019-11-14T08:37:10-05:00Categories: Press Release|Tags: Drug_Abuse, Pharmacy_Value, Reimbursement, States|

Substance use disorder (SUD) treatment could benefit from pharmacists’ accessibility and expertise, NACDS wrote in detailed letters to 15 Medicaid program directors.

National Association of Chain Drug StoresPharmacies. The face of neighborhood healthcare.